These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 7004396)

  • 21. [Comparative immunomorphological study of the immunogenic activity of dysentery vaccines produced by different methods].
    Belaia IuA; Rukhamina ML; Nguyen ZH
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jul; (7):64-70. PubMed ID: 6353818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Stimulation of antidysentery immunity with acetoxan].
    Gorbunova ES
    Antibiotiki; 1966 Apr; 11(4):354-8. PubMed ID: 4861976
    [No Abstract]   [Full Text] [Related]  

  • 23. [Content of A-, G- and M-class immunoglobulins in adults perorally immunized with a liver Sonne dysentery vaccine].
    Kuz'min SN; Belaia IuA; Birkovskiĭ IuE; Milovanova LP; Pavlova LI
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Sep; (9):47-52. PubMed ID: 371307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of human serum bactericidal activity by specific IgM antibodies of normal and anti-O immune rabbit sera against pseudo-serum-resistant strains of Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol A; 1980 Feb; 246(1):50-66. PubMed ID: 6999780
    [No Abstract]   [Full Text] [Related]  

  • 25. [Trial of the protective activity of ribosomal Sonne vaccine in monkeys].
    Levenson VI; Dzhikidze EK; Stasilevich ZK; Kavtaradze KN; Subbotina IuL
    Vestn Akad Med Nauk SSSR; 1986; (3):69-72. PubMed ID: 3518271
    [No Abstract]   [Full Text] [Related]  

  • 26. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
    Shim DH; Chang SY; Park SM; Jang H; Carbis R; Czerkinsky C; Uematsu S; Akira S; Kweon MN
    Vaccine; 2007 Jun; 25(25):4828-36. PubMed ID: 17507120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shigella Sonnei vaccine.
    Drugs R D; 1999 Sep; 2(3):222-3. PubMed ID: 10641235
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies of crossed immunity between different serotypes of dysentery bacilli and the keratoconjunctivitis-positive, lactoso-negative strain 47552 deprived of Shigella agglutinogen].
    Ciufeco C
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):389-94. PubMed ID: 4925072
    [No Abstract]   [Full Text] [Related]  

  • 31. Utilization of differentiation of antibodies to Shigella organisms according to the immunoglobulin class in the serological diagnostics of dysentery and in study of its epidemiology.
    Hasenson LB; Gennadeva TY; Lullu AV
    J Hyg Epidemiol Microbiol Immunol; 1971; 15(3):298-307. PubMed ID: 4938457
    [No Abstract]   [Full Text] [Related]  

  • 32. Vaccine potential for inactivated shigellae.
    Osorio M; Bray MD; Walker RI
    Vaccine; 2007 Feb; 25(9):1581-92. PubMed ID: 17178431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune response to Shigella sonnei in U.S. Marines.
    Mikhail MM; Mansour MM; Oyofo BA; Malone JD
    Infect Immun; 1996 Sep; 64(9):3942-5. PubMed ID: 8751956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunoglobulin and antibody content in the blood serum, coprofiltrate and saliva of patients with Sonne dysentery].
    Kuz'min SN; Belaia IuA; Kul'berg AIa; Sukhoroslova LI; Mel'nik ZG
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jun; (6):66-71. PubMed ID: 354289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Using the differentiation of antibodies to shigellae according to the immunoglobulin classes in studying the epidemiology of dysentery].
    Khazenson LB; Gennad'eva TIa; Lullu AV
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1970; 36():81-6. PubMed ID: 4938214
    [No Abstract]   [Full Text] [Related]  

  • 36. [Study of the immunological effectiveness of the enteral vaccination of volunteers with detergent Sonne dysentery monovaccine].
    Shpiliuk GF; Gennad'eva TIa; Khazenson LB; Kambarova OI; Sel'kina LE
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Aug; (8):26-31. PubMed ID: 335740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Reactogenicity and immunologic activity of live enteric Sonne dysentery vaccine from a spontaneous mutant].
    Belaia IuA; Pavlova LI; Sukhareva ME; Kuz'min SN; Teleshevskaia EA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):111-7. PubMed ID: 324177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
    Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
    J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory control of oral Shigella sonnei vaccine.
    Starke G; Thilo W
    Prog Immunobiol Stand; 1970; 4():363-7. PubMed ID: 4921390
    [No Abstract]   [Full Text] [Related]  

  • 40. Cell wall structures which may be important for successful immunization with Salmonella-Shigella hybrid vaccines.
    Schultz CL; Kaufman B; Hamilton D; Hartman A; Ruiz M; Powell C; Berman S
    Vaccine; 1990 Apr; 8(2):115-20. PubMed ID: 2159678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.